FdaApplication
BLA 761029
Identifiers
- fda_app_no: BLA761029
Properties
| Property | Value |
|---|---|
| applicant_name | Biogen Inc. |
| application_type | BLA |
| approval_date | 2016-05-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZINBRYTA | DACLIZUMAB | 150MG/ML | Injection |
| ZINBRYTA | — | 150MG/ML | Injection |
2 products